# Meduloc

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/meduloc

- Industry: Medical Devices & Equipment
- Headquarters: Del Mar, US
- Website: www.meduloc.com/
- Total disclosed funding: $1.8M
- Latest round: Series B (Jul 24, 2026)
- Investors on record: 4

## About

Based in California, US and founded in 2016, Meduloc, Inc., was co-founded by Joshua Hustedto, Benjamin Arnold, and Brian Bowman. Sarah Sachinis is the CEO of the firm. It develops innovative implants designed to improve the treatment of small and long-bone fractures while minimizing soft tissue disruption and supporting better clinical outcomes. In July 2026, Meduloc raised USD 1.84 million in series B funding led by GenHenn Capital, with participation from Life Sciences Greenhouse Investments, Ben Franklin Technology Partners, Broad Street Angels. Meduloc develops minimally invasive intramedullary implants used for the fixation and reduction of small and long-bone fractures. Its solutions are designed for applications involving metacarpal, metatarsal, phalange, clavicle, radius, ulna, and fibula fractures, offering rotational stability and soft tissue preservation. Meduloc generates revenue through the development, commercialization, and distribution of orthopedic fixation implants and related surgical solutions. The company also derives revenue from supplying proprietary fracture fixation systems to healthcare providers, surgeons, and medical distributors.

## Funding rounds

- Series B, Jul 24, 2026, $1.8M — Ben Franklin Technology Partners, Life Sciences Greenhouse of Central Pennsylvania, Broad Street Angels, GenHenn Capital

## Investors

- Ben Franklin Technology Partners (https://capitalatlas.ai/funds/ben-franklin-technology-partners) — Series B
- Life Sciences Greenhouse of Central Pennsylvania — Series B
- Broad Street Angels — Series B
- GenHenn Capital — Series B